5,7,4'-Trihydroxyflavone-3-yl 2-O-(alpha-L-rhamnopyranosyl)-6-O-[2-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-alpha-L-rhamnopyranosyl]-beta-D-galactopyranoside

Details

Top
Internal ID db50b3c7-df08-42ab-9a14-8ef501555644
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Flavonoid glycosides > Flavonoid O-glycosides > Flavonoid-3-O-glycosides
IUPAC Name [(2R,3R,4R,5R,6S)-2-[[(2R,3R,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4-dihydroxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-methyloxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)COC6C(C(C(C(O6)C)O)O)OC(=O)C=CC7=CC(=C(C=C7)O)OC)O)O)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H]([C@H](O[C@H]2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)CO[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)OC(=O)/C=C/C7=CC(=C(C=C7)O)OC)O)O)O)O)O
InChI InChI=1S/C43H48O22/c1-16-29(49)33(53)36(56)41(59-16)65-40-35(55)31(51)26(15-58-42-39(34(54)30(50)17(2)60-42)63-27(48)11-5-18-4-10-22(46)24(12-18)57-3)62-43(40)64-38-32(52)28-23(47)13-21(45)14-25(28)61-37(38)19-6-8-20(44)9-7-19/h4-14,16-17,26,29-31,33-36,39-47,49-51,53-56H,15H2,1-3H3/b11-5+/t16-,17-,26+,29-,30-,31-,33+,34+,35-,36+,39+,40+,41-,42+,43-/m0/s1
InChI Key OYMFGCWYYJYUKC-VYEJHIHYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C43H48O22
Molecular Weight 916.80 g/mol
Exact Mass 916.26372315 g/mol
Topological Polar Surface Area (TPSA) 340.00 Ų
XlogP 0.30
Atomic LogP (AlogP) -0.56
H-Bond Acceptor 22
H-Bond Donor 11
Rotatable Bonds 12

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 5,7,4'-Trihydroxyflavone-3-yl 2-O-(alpha-L-rhamnopyranosyl)-6-O-[2-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-alpha-L-rhamnopyranosyl]-beta-D-galactopyranoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.5530 55.30%
Caco-2 - 0.8823 88.23%
Blood Brain Barrier - 0.8000 80.00%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.5729 57.29%
OATP2B1 inhibitior - 0.7103 71.03%
OATP1B1 inhibitior + 0.8549 85.49%
OATP1B3 inhibitior + 0.9478 94.78%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior + 0.7708 77.08%
P-glycoprotein inhibitior + 0.6801 68.01%
P-glycoprotein substrate + 0.7163 71.63%
CYP3A4 substrate + 0.7056 70.56%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8718 87.18%
CYP3A4 inhibition - 0.9007 90.07%
CYP2C9 inhibition - 0.8872 88.72%
CYP2C19 inhibition - 0.9236 92.36%
CYP2D6 inhibition - 0.9301 93.01%
CYP1A2 inhibition - 0.9344 93.44%
CYP2C8 inhibition + 0.8975 89.75%
CYP inhibitory promiscuity - 0.7459 74.59%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6348 63.48%
Eye corrosion - 0.9901 99.01%
Eye irritation - 0.9052 90.52%
Skin irritation - 0.8375 83.75%
Skin corrosion - 0.9543 95.43%
Ames mutagenesis - 0.6165 61.65%
Human Ether-a-go-go-Related Gene inhibition + 0.6433 64.33%
Micronuclear + 0.7092 70.92%
Hepatotoxicity - 0.6625 66.25%
skin sensitisation - 0.9161 91.61%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.9811 98.11%
Acute Oral Toxicity (c) III 0.5848 58.48%
Estrogen receptor binding + 0.7893 78.93%
Androgen receptor binding + 0.6388 63.88%
Thyroid receptor binding + 0.5372 53.72%
Glucocorticoid receptor binding + 0.6842 68.42%
Aromatase binding + 0.5872 58.72%
PPAR gamma + 0.7485 74.85%
Honey bee toxicity - 0.6835 68.35%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.9530 95.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.83% 91.11%
CHEMBL1806 P11388 DNA topoisomerase II alpha 99.20% 89.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 98.81% 86.33%
CHEMBL1951 P21397 Monoamine oxidase A 97.70% 91.49%
CHEMBL3194 P02766 Transthyretin 95.96% 90.71%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 94.78% 96.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.75% 96.09%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 94.63% 95.64%
CHEMBL3060 Q9Y345 Glycine transporter 2 93.86% 99.17%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.26% 95.56%
CHEMBL2581 P07339 Cathepsin D 92.03% 98.95%
CHEMBL3401 O75469 Pregnane X receptor 91.04% 94.73%
CHEMBL2085 P14174 Macrophage migration inhibitory factor 88.76% 80.78%
CHEMBL3714130 P46095 G-protein coupled receptor 6 88.04% 97.36%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 87.48% 95.50%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.41% 94.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 85.58% 94.45%
CHEMBL4208 P20618 Proteasome component C5 85.51% 90.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 84.05% 99.15%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 82.71% 95.89%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 82.41% 95.78%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 81.91% 89.62%
CHEMBL242 Q92731 Estrogen receptor beta 81.31% 98.35%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 80.31% 91.71%

Cross-Links

Top
PubChem 101781229
NPASS NPC312368